[ad_1]
October 16, 2025
1 min read
Key takeaways:
- RetinAI Discovery is a platform for patient management and AI-based disease monitoring.
- The acquisition is part of EssilorLuxottica’s strategy to enlarge its medical technology portfolio.
Editor’s note: This is a developing news story. Please check back soon for updates.
EssilorLuxottica added to its medical technology portfolio with the acquisition of Ikerian AG, a Swiss health tech company doing business under the name RetinAI, according to a press release.
The company’s flagship product is RetinAI Discovery, a clinical software platform for managing patient data and imagery, with AI-based disease monitoring capabilities. It also makes Discovery Unity, another data management platform geared toward clinical studies and pharmaceutical research and development.
“RetinAI will add incredible value to an ecosystem that already includes comprehensive eye care, advanced diagnostics, therapeutic innovation and surgical excellence,” Francesco Milleri, chairman and CEO of EssilorLuxottica, said in the release. “Leveraging its AI-powered analytics, we can turn clinical data into insights that enable faster, more accurate diagnoses and more effective disease monitoring.”
RetinAI’s acquisition marks “an exciting new chapter for our team and technology,” Carlos Ciller, PhD, chairman and CEO of RetinAI/Ikerian AG, said in the release.
“From the start, we’ve believed in the power of data and AI to transform patient care,” Ciller said. “With EssilorLuxottica’s global reach and deep commitment to innovation, we can now bring that vision to life at an entirely new scale and level of positive impact. Together, we’ll shape how technology drives better health care, shaper vision and improved outcomes for patients.”
EssilorLuxottica’s latest acquisition is part of a strategy to enlarge its footprint in medical technology. It comes after the December acquisition of Espansione Group, an Italian company specializing in noninvasive eye care devices.
Milleri said the goal of EssilorLuxottica’s moves into medical technology is “building the most comprehensive, digitally enabled patient journey.”
“We are ushering in a new era of health care, and it will be transformative for patients everywhere,” he said.
[ad_2]
Source link
